Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus

Area of Science:

• Molecular Biology
• Cell Biology
• Developmental Biology

Background:

• Chondrocyte differentiation and maintenance depend on the transcription factor Sox9.
• Wnt/beta-catenin signaling, activated by extrinsic Wnt ligands, inhibits chondrogenesis.
• Understanding how Sox9 counteracts Wnt/beta-catenin signaling is crucial for chondrocyte biology.

Purpose of the Study:

• To elucidate the molecular mechanisms by which Sox9 antagonizes Wnt/beta-catenin signaling during chondrocyte differentiation.
• To investigate the distinct roles of Sox9's N and C termini in regulating beta-catenin.

Main Methods:

• Investigated the interaction of Sox9 with beta-catenin and its destruction complex components (GSK3, BTRC).
• Assessed the impact of Sox9 on beta-catenin phosphorylation, degradation, and transcriptional activity.
• Examined the role of Sox9's nuclear localization and DNA-binding ability in these processes.

Main Results:

• Sox9 utilizes two distinct mechanisms to inhibit Wnt/beta-catenin signaling.
• The Sox9 N terminus promotes beta-catenin degradation by enhancing its nuclear localization with destruction complex components.
• The Sox9 C terminus inhibits beta-catenin transcriptional activity without affecting its stability.

Conclusions:

• Sox9 promotes chondrogenesis by enhancing nuclear beta-catenin phosphorylation and degradation.
• This mechanism of Sox9 antagonizing Wnt signaling may be a general strategy for intrinsic transcription factors.
• Sox9's dual action provides critical regulation of chondrocyte fate and maintenance.